Abcellera Warns Growing Generative AI Use Raises Cybersecurity, Privacy, and Operational Risks

Abcellera Biologics, Inc. (ABCL) has disclosed a new risk, in the Cyber Security category.

Abcellera Biologics, Inc. faces growing risk as it and its vendors adopt generative AI tools that may not align with evolving privacy, security, and data protection standards, increasing exposure to breaches and service disruption. Any actual or perceived AI-related incident, including theft or misuse of confidential or personal data by bad actors, could cause loss of intellectual property, reputational damage, and materially harm its business operations.

The average ABCL stock price target is $7.00, implying 119.44% upside potential.

To learn more about Abcellera Biologics, Inc.’s risk factors, click here.